Haemonetics Corporation Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31)
Haemonetics Corporation (HAE) reported Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) of -$3.23 million for the 12-month period ending 2012-03-31, per its 10-K filed 2012-05-22.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax · last filed 2012-05-22
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was -$144.00K.
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was -$190.00K, a 522.22% decline year-over-year.
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-10-01 was -$1.26M.
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for the quarter ending 2011-07-02 was -$1.64M, a 5380.65% decline year-over-year.
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2012 was -$3.23M.
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$769.00K.
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2010 was -$809.00K.
- Haemonetics Corporation other comprehensive income (loss), reclassification adjustment on derivatives included in net income, net of tax (deprecated 2012-01-31) for fiscal 2009 was -$4.36M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment on Derivatives Included in Net Income, Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | -$144.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-22 | -$334.00K derived: sum of 2 quarters · filed 2012-05-22 | -$1.59M derived: sum of 3 quarters · filed 2012-05-22 | -$3.23M 10-K · filed 2012-05-22 |
| 2011-12-31 | -$190.00K 10-Q · filed 2012-02-06 | -$1.45M derived: sum of 2 quarters · filed 2012-02-06 | -$3.09M 10-Q · filed 2012-02-06 | -$3.78M derived: sum of 4 quarters · filed 2012-05-22 |
| 2011-10-01 | -$1.26M 10-Q · filed 2011-11-03 | -$2.90M 10-Q · filed 2011-11-03 | -$3.59M derived: sum of 3 quarters · filed 2012-05-22 | -$3.55M derived: sum of 4 quarters · filed 2012-05-22 |
| 2011-07-02 | -$1.64M 10-Q · filed 2011-08-10 | -$2.33M derived: sum of 2 quarters · filed 2012-05-22 | -$2.29M derived: sum of 3 quarters · filed 2012-05-22 | -$2.44M derived: sum of 4 quarters · filed 2012-05-22 |
| 2011-04-02 | -$696.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-22 | -$651.00K derived: sum of 2 quarters · filed 2012-05-22 | -$800.00K derived: sum of 3 quarters · filed 2012-05-22 | -$769.00K 10-K · filed 2012-05-22 |
| 2011-01-01 | $45.00K 10-Q · filed 2012-02-06 | -$104.00K derived: sum of 2 quarters · filed 2012-02-06 | -$73.00K 10-Q · filed 2012-02-06 | |
| 2010-10-02 | -$149.00K 10-Q · filed 2011-11-03 | -$118.00K 10-Q · filed 2011-11-03 | ||
| 2010-07-03 | $31.00K 10-Q · filed 2011-08-10 | |||
| 2010-04-03 | -$809.00K 10-K · filed 2012-05-22 | |||
| 2009-03-28 | -$4.36M 10-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |